Related Experiment Video
Updated: Sep 6, 2025
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.4K
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
Giuseppe Mandraffino1, Alessandro Mattina2, Roberto Scicali3
1Internal Medicine Unit, Lipid Center, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
Biomolecules
|June 24, 2022
Insights
Atherosclerosis is a chronic inflammatory disease causing progressive damage to blood vessels. Understanding its mechanisms is key to preventing cardiovascular injury.
Area of Science:
- Cardiovascular Science
- Pathology
- Immunology
Background:
- Atherosclerosis is a chronic inflammatory disease characterized by the buildup of plaques in arteries.
- This process can lead to significant cardiovascular injury, including heart attack and stroke.
- The underlying mechanisms driving atherosclerosis progression are complex and multifactorial.
Discussion:
- The study investigates the long-term damaging processes involved in atherosclerosis.
- It highlights the link between chronic inflammation and arterial wall injury.
- Further research is needed to fully elucidate the molecular pathways.
Key Insights:
- Atherosclerosis is a progressive condition with long-term detrimental effects on the cardiovascular system.
- The disease involves sustained damage to blood vessels.
- Early detection and intervention are crucial for managing atherosclerosis.
Outlook:
- Future research should focus on novel therapeutic targets to halt or reverse atherosclerotic progression.
- Developing strategies to mitigate chronic inflammation may prevent cardiovascular events.
- Continued investigation into the pathogenesis of atherosclerosis is essential for improving patient outcomes.
Abstract:
Atherosclerosis is a long-term damaging process, and its progression leads to cardiovascular system injury [...].
Related Concept Videos
01:26Atherosclerosis III: Management
31
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
36
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
36
01:30Coronary Artery Disease I: Introduction
53
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:30Atherosclerosis I: Introduction
73
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
73